TLX

Listed Company

TELIX Pharmaceuticals Ltd (ASX TLX)

Followers 156

Exchange ASX

Sector Health Care

Industry Pharmaceuticals, Biotechnology & Life Sciences

Popular News mentioning ASX TLX

Be greedy when others are fearful: Why now is the time to invest in healthcare

Be greedy when others are fearful: Why now is the time to invest in healthcare

With the healthcare sector in a deep and prolonged downturn, valuations of public and private R&D stage companies are very attractive.

Hashan De Silva,

KP Rx

This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.

This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.

The KP Rx Healthcare Opportunities Fund is targeting Australia & New Zealand's most innovative healthcare companies. Find out how they do it

Chris Conway,

Livewire Markets

Why Australian small caps are looking promising and three stocks to watch

Why Australian small caps are looking promising and three stocks to watch

The market is looking supportive of valuations and Eiger Capital's Stephen Wood sees opportunities.

Sara Allen,

Livewire Markets

Buy Hold Sell: Your 5 top small and mid-cap stocks for 2024 (and 2 big fundie buys)

Buy Hold Sell: Your 5 top small and mid-cap stocks for 2024 (and 2 big fundie buys)

In this episode, T. Rowe Price's Randal Jenneke and Tribeca's Jun Bei Liu analyse your favourite small and mid-cap stocks for the year.

Buy Hold Sell,

Livewire Markets

Be greedy when others are fearful: Why now is the time to invest in healthcare

Be greedy when others are fearful: Why now is the time to invest in healthcare

Hashan De Silva,

KP Rx

This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.

This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.

Chris Conway,

Livewire Markets

Why Australian small caps are looking promising and three stocks to watch

Why Australian small caps are looking promising and three stocks to watch

Sara Allen,

Livewire Markets

Buy Hold Sell: Your 5 top small and mid-cap stocks for 2024 (and 2 big fundie buys)

Buy Hold Sell: Your 5 top small and mid-cap stocks for 2024 (and 2 big fundie buys)

Buy Hold Sell,

Livewire Markets

Watch

This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.

Chris Conway,

Livewire Markets

Advertisement

Advertisement

Latest News on TELIX Pharmaceuticals Ltd

Equities

May 13, 2024 08:38

Be greedy when others are fearful: Why now is the time to invest in healthcare

With the healthcare sector in a deep and prolonged downturn, valuations of public and private R&D stage companies are very attractive.

Hashan De Silva

Hashan De Silva

KP Rx

May 13, 2024 08:38

Undiscovered Funds

May 02, 2024 11:00

This fundie invested in Neuren at a $70m valuation. It's now $2.4 billion.

The KP Rx Healthcare Opportunities Fund is targeting Australia & New Zealand's most innovative healthcare companies. Find out how they do it

Chris Conway

Chris Conway

Livewire Markets

May 02, 2024 11:00

Equities

April 23, 2024 16:18

Why we believe Telix Pharmaceuticals is an attractive investment

Uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts.

Sean Sequeira

Sean Sequeira

Australian Eagle Asset Management

April 23, 2024 16:18

Equities

April 22, 2024 09:00

The Australian small-cap that could become the next CSL

Monash Investors’ Shane Fitzgerald discusses his outlook for ASX small-caps and some of his team’s highest conviction stock picks.

Glenn Freeman

Glenn Freeman

Livewire Markets

April 22, 2024 09:00

Daily Report

April 18, 2024 17:42

ASX 200 bounces! Gold, copper and metals rallies still running hot as brokers update BOQ, EVN, and RIO

Most of the ASX200's gain came from heavyweights Resources and Financials but gold and metals stocks featured highly in the best performers.

Carl Capolingua

Carl Capolingua

Livewire Markets

April 18, 2024 17:42

Covering TELIX Pharmaceuticals Ltd

David Thornton

Livewire Markets

Buy Hold Sell

Livewire Markets

The Morning Wrap

Livewire Markets

James Gerrish

Market Matters

Carl Capolingua

Livewire Markets

Ally Selby

Livewire Markets

TELIX Pharmaceuticals Ltd (ASX:TLX) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is TLX. Livewire Markets has 28 experts who have published 68 articles that have featured TELIX Pharmaceuticals Ltd. You can view all those wires here. The last time time TLX was featured was on the 13 May 2024 by Hashan De Silva in the wire “Be greedy when others are fearful: Why now is the time to invest in healthcare”. Get the latest TLX share price and other key information like TLX Financials on Market Index.